Osaka Organic Chemical Industry Ltd.TSE: 4187

Consolidated Financial Results for the Fiscal Year Ended November 30, 2024(January 9, 2025 410KB)

· Issued by Osaka Organic Chemical Industry Ltd.

Note: This document has been translated from the Japanese original for reference purposes only. In the event of any discrepancy between this translated document and the Japanese original, the original shall prevail.

Consolidated Financial Results

for the Year Ended November 30, 2024

[Japanese GAAP]

January 9, 2025

Company name: OSAKA ORGANIC CHEMICAL INDUSTRY LTD.

Listing: Tokyo

Securities code: 4187

URL: https://www.ooc.co.jp/

Representative: Masayuki Ando

Representative Director and CEO

Inquiries: Soichi Honda

Director, Corporate Officer, General Manager of Administration

Division

Telephone: +81-(0)6-6264-5071

Scheduled date of annual general meeting of shareholders: February 27, 2025

Scheduled date to commence dividend payments: February 28, 2025

Scheduled date to file annual securities report: February 28, 2025

Preparation of supplementary material on financial results: Yes

Holding of financial results briefing: Yes (for institutional investors and analysts, and individual investors)

(Yen amounts are rounded down to millions, unless otherwise noted.)

1. Consolidated Financial Results for the Fiscal Year Ended November 30, 2024 (December 1, 2023 to November 30, 2024)

(1) Consolidated Operating Results

(Percentages indicate year-on-year changes.)

Net sales

Operating profit

Ordinary profit

Profit attributable to

owners of parent

Fiscal year ended

Millions of yen

%

Millions of yen

%

Millions of yen

%

Millions of yen

%

November 30, 2024

32,698

13.1

4,608

28.8

4,753

22.6

4,044

23.7

November 30, 2023

28,907

(10.3)

3,577

(39.7)

3,877

(39.1)

3,270

(30.8)

(Note) Comprehensive income:

Fiscal year ended November 30, 2024:

Fiscal year ended November 30, 2023:

¥

4,219 million

[

5.0%]

¥

4,019 million

[

(17.0) %]

Basic earnings per

Diluted earnings per

Rate of return on

Ordinary profit to

Operating profit to

share

share

equity

total assets ratio

net sales ratio

Fiscal year ended

Yen

Yen

%

%

%

November 30, 2024

191.25

-

9.1

8.3

14.1

November 30, 2023

152.94

-

7.8

7.2

12.4

(Reference) Equity in earnings (losses) of affiliated companies: Fiscal year ended November 30, 2024: Fiscal year ended November 30, 2023:

(2) Consolidated Financial Position

  • - million
  • - million

Total assets

Net assets

Capital adequacy ratio

Net assets per share

As of

Millions of yen

Millions of yen

%

Yen

November 30, 2024

59,964

46,139

75.8

2,150.61

November 30, 2023

54,636

43,629

78.7

2,021.12

(Reference) Equity: As of

November 30, 2024:

¥

45,435 million

As of

November 30, 2023:

¥

42,984 million

(3) Consolidated Cash Flows

Cash flows from

Cash flows from

Cash flows from

Cash and cash

equivalents at the end

operating activities

investing activities

financing activities

of period

Fiscal year ended

Millions of yen

Millions of yen

Millions of yen

Millions of yen

November 30, 2024

8,600

(298)

(3,127)

13,047

November 30, 2023

4,370

(4,127)

(476)

7,890

2. Dividends

Annual dividends

Payout

Dividends

Total

to net

ratio

dividends

assets

1st

2nd

3rd

Year-end

Total

(consolidated)

quarter-end

quarter-end

quarter-end

(consolidated)

Fiscal year ended

Yen

Yen

Yen

Yen

Yen

Millions of yen

%

%

November 30, 2023

-

28.00

-

28.00

56.00

1,190

36.6

2.9

November 30, 2024

-

32.00

-

34.00

66.00

1,394

34.5

3.2

Fiscal year ending

November 30, 2025

-

34.00

-

34.00

68.00

41.1

(Forecast)

3. Consolidated Financial Results Forecast for the Fiscal Year Ending November 30, 2025 (December 1, 2024 to November 30, 2025) (Percentages indicate year-on-year changes.)

Net sales

Operating profit

Ordinary profit

Profit attributable to

Basic earnings

owners of parent

per share

Millions of

Millions of

Millions of

Millions of

Six months ending May

yen

%

yen

%

yen

%

yen

%

Yen

16,800

9.5

2,500

34.4

2,600

30.7

1,700

(15.8)

81.00

31, 2025

Full year

34,000

4.0

5,000

8.5

5,200

9.4

3,500

(13.5)

165.50

* Notes:

(1) Significant changes in the scope of consolidation during the period:

None

Newly included:

-

(Company name:

)

Excluded:

-

(Company name:

)

  1. Changes in accounting policies, changes in accounting estimates, and restatement
    1. Changes in accounting policies due to revisions to accounting standards and other regulations: None
    2. Changes in accounting policies due to other reasons: None
    3. Changes in accounting estimates: None
    4. Restatement: None
  2. Number of issued shares (common shares)
    1. Total number of issued shares at the end of the period (including treasury shares):

November 30, 2024:

22,410,038

shares

November 30, 2023:

22,410,038

shares

2) Number of treasury shares at the end of the period:

November 30, 2024:

1,283,303

shares

November 30, 2023:

1,142,585

shares

3) Average number of shares outstanding during the period:

Fiscal Year ended November 30, 2024:

21,147,955

shares

Fiscal Year ended November 30, 2023:

21,387,005

shares

*Financial statements are not subject to audits by certified public accountants or auditing firms. *Cautionary statement with respect to forecasts of financial results and other special items

The forward-looking statements in this document, including forecasts of financial results, are based on information currently available to the Company and are subject to a number of uncertainties. Accordingly, actual results may differ from the forecasts due to changes in business conditions and other factors. Please refer to "1. Overview of Results of Operations, (4) Outlook" on page 3 of the attached materials for matters related to forecasts of financial results.

OSAKA ORGANIC CHEMICAL INDUSTRY LTD. (4187) Financial Results for FY11/24

  • Contents of Attachments

1. Overview of Results of Operations

2

(1)

Results of Operations

2

(2)

Financial Position

3

(3)

Cash Flows

3

(4)

Outlook

3

(5)

Basic Policy for Profit Distribution, and Dividends in the Current and Next Fiscal Years

5

2. Basic Approach for the Selection of Accounting Standards

5

3. Consolidated Financial Statements and Notes

6

(1)

Consolidated Balance Sheet

6

(2)

Consolidated Statements of Income and Comprehensive Income

8

Consolidated Statement of Income

8

Consolidated Statement of Comprehensive Income

9

(3)

Consolidated Statement of Changes in Equity

10

(4)

Consolidated Statement of Cash Flows

12

(5)

Notes to Consolidated Financial Statements

14

Going Concern Assumption

14

Changes in Presentation Method

14

Segment and Other Information

14

Per-share Information

17

Significant Subsequent Events

17

1

OSAKA ORGANIC CHEMICAL INDUSTRY LTD. (4187) Financial Results for FY11/24

1. Overview of Results of Operations

(1) Results of Operations

During the fiscal year under review, in the Japanese economy, business conditions maintained a moderate recovery trend due to the improvement in the employment and income situation and the effects of various policies. On the other hand, high interest rates in Europe and the United States and the stagnation of the real estate market in China pose a risk that the downturn in overseas economies could exert downward pressure on the Japanese economy. In addition, the outlook remains uncertain due to price increases, conditions surrounding the Middle East region, changes in the financial and capital markets, and other factors.

Under these circumstances, we launched a new medium-term management planning Progress & Development 2030 (P&D 2030) for the period from the fiscal year ended November 30, 2024 to the fiscal year ending November 30, 2030. Based on our Group management philosophy, P&D 2030 has set a management vision of "providing value to the global market as a leading company in specialty acrylic acid esters." Under this vision, we will promote sustainable management that takes ESG into account, aiming to increase corporate value and achieve sustainable growth.

In the Chemicals Business, we worked to improve profitability by integrating and closing products, and focused on expanding sales of environmentally friendly products, such as those derived from biomass. In the Electronics Materials Business, the Group worked to accelerate the development of cutting-edge semiconductor materials and to develop new applications for photoresist materials. In the functional chemicals business, the Group worked to strengthen the overseas expansion of cosmetic raw materials and expand sales of high-purity special solvents. In July 2024, we established a subsidiary in South Korea. Going forward, we will work to strengthen our overseas sales system by acquiring new customers and cultivating new markets.

As a result, for the fiscal year under review, net sales were 32,698 million yen (up 13.1% year on year), operating profit was 4,608 million yen (up 28.8% year on year), ordinary profit was 4,753 million yen (up 22.6% year on year), and profit attributable to owners of parent was 4,044 million yen (up 23.7% year on year).

① Business results by segment are explained below (excluding inter-segment transactions). Chemical products

In the Chemicals Business, sales of the acrylic acid ester group for automotive coatings decreased, but sales for display adhesives increased significantly, along with increased sales for UV inkjet inks. In the methacrylate group, sales were strong. As a result, net sales were 12,513 million yen (up 21.5% year on year) and segment profit was 1,978

②million yen (up 108.7% year on year). Electronics materials

In the Electronic Materials Business, sales of raw materials for cutting-edge EUV resists increased significantly. However, while sales of raw materials for ArF resists, which are the Company's mainstay, showed a recovery trend from sluggish demand due to inventory adjustments, Group-wide sales growth fell short of our expectations. In the display materials group, despite an increase in sales for insulating films for touch panels, sales for the group as a whole were flat. In addition, sales of other groups' new display materials, etc. increased. As a result, net sales were 14,374

③million yen (up 12.5% year on year) and segment profit was 1,869 million yen (up 12.4% year on year). Specialty chemicals

In the Specialty Chemicals Business, raw materials for cosmetics recorded strong sales abroad. As for functional materials, sales of products made for other companies remained weak. Sales of high-purity specialty solvents and other products at subsidiaries remained solid. As a result, net sales were 5,810 million yen (down 0.3% year on year) and segment profit was 771 million yen (down 20.8% year on year).

2

OSAKA ORGANIC CHEMICAL INDUSTRY LTD. (4187) Financial Results for FY11/24

(2) Financial Position

Total assets at the end of the fiscal year under review increased by 5,327 million yen from the end of the previous fiscal year to 59,964 million yen. This was mainly attributable to an increase of 5,156 million yen in cash and deposits, an increase of 2,513 million yen in accounts receivable - trade due to the last day of the fiscal year under review being a holiday for financial institutions, a decrease of 2,028 million yen in property, plant and equipment, and a decrease of 302 million yen in investment securities.

Liabilities at the end of the fiscal year under review increased by 2,816 million yen from the end of the previous fiscal year to 13,824 million yen. This was mainly due to an increase of 2,122 million yen in notes and accounts payable - trade, mainly due to the last day of the fiscal year under review being a holiday for financial institutions and an increase of 660 million yen in income taxes payable.

Net assets at the end of the fiscal year under review increased by 2,510 million yen from the end of the previous fiscal year to 46,139 million yen. This was mainly due to an increase of 2,773 million yen in retained earnings, an increase of 419 million yen in treasury shares, a decrease of 170 million yen in valuation difference on available-for-sale securities, and an increase of 259 million yen in remeasurements of defined benefit plans.

(3) Cash Flows

During the fiscal year under review, cash and cash equivalents (hereinafter referred to as "funds") increased by 5,156 million yen to 13,047 million yen (up 65.4% year on year), mainly due to 298 million yen invested in investing activities from 8,600 million yen provided by operating activities and a decrease of 3,127 million yen in financing activities.

(Cash flows from operating activities)

Net cash provided by operating activities was 8,600 million yen (net cash provided of 4,370 million yen in the previous fiscal year) due to profit before income taxes of 5,567 million yen, depreciation of 3,283 million yen, and income taxes refund (paid) of 850 million yen.

(Cash flows from investing activities)

Net cash used in investing activities was 298 million yen (net cash used of 4,127 million yen in the previous fiscal year). This was mainly due to purchase of property, plant and equipment of 1,027 million yen associated with the construction of new facilities, etc., and proceeds from sale of investment securities of 1,054 million yen.

(Cash flows from financing activities)

Net cash used in financing activities was 3,127 million yen (net cash used of 476 million yen in the previous fiscal year) due to proceeds from long-term borrowings of 400 million yen for the construction of new facilities, 1,771 million yen of repayments of long-term borrowings, 427 million yen of purchase of treasury shares, and 1,271 million yen of dividends paid.

(4) Outlook

With regard to the future outlook, uncertainty is expected to persist due to factors such as the possibility of an economic slowdown overseas, particularly in China, price hikes due to soaring fuel and raw material prices, heightened geopolitical risks such as the situation in Ukraine and the situation in the Middle East, and the impact of potential policy changes following the U.S. administration transition.

Under these circumstances, we launched a new medium-term management planning Progress & Development 2030

3

OSAKA ORGANIC CHEMICAL INDUSTRY LTD. (4187) Financial Results for FY11/24

(P&D 2030) for the period from the fiscal year ended November 30, 2024 to the fiscal year ending November 30, 2030. Under the new medium-term management plan P&D 2030, we will promote sustainable management with consideration for ESG under the management vision of "providing value to the global market as a leading company in

specialty acrylic acid esters" based on our group management philosophy.

As for business domains, our basic strategy is to expand our focus areas by accelerating the development of cutting- edge semiconductor materials, expanding our semiconductor business by rolling out into peripheral materials, expanding our LCD resist design technology to non-display applications, expanding our hydrophilic polymer technology to bio-compatible materials and new electronic materials applications, collaborating with other organizations and manufacturers related to organic piezoelectric materials and flexible elastomer materials, and launching new markets.

In addition, the Group will strive to develop materials for the environmental community through measures such as developing biomass acrylate, going downstream, developing acrylic acid derived from non-fossil raw materials, taking on the challenge of completely non-fossil-based materials, and disclosing environmental data such as LCA.

To strengthen our overseas strategy, we will establish sales companies in China, South Korea, and North America, enhance our channel strategy, including local production, and expand sales channels to ASEAN, India, and other countries, centered on cosmetics materials.

In initiatives related to sustainability, we aim to contribute to a sustainable society by implementing measures aimed at achieving carbon neutrality, reducing waste, and reusing resources to realize a circular economy.

Through the promotion of IT and DX, we will work to improve quality, prevent problems, improve safety, and improve productivity. At the same time, we will improve employee job satisfaction and engagement by optimizing the working environment and working styles, create a framework for diversifying employment, and implement human capital management such as education and human resource development tailored to the environment and strategy.

Furthermore, we will strengthen risk management by ensuring thorough compliance, strengthening the supply chain, and enhancing the viability of BCP.

Taking these factors into account, we plan to achieve the following performance targets: net sales of 34,000 million yen, operating profit of 5,000 million yen, ordinary profit of 5,200 million yen, and profit attributable to owners of the parent of 3,500 million yen.

4

OSAKA ORGANIC CHEMICAL INDUSTRY LTD. (4187) Financial Results for FY11/24

(5) Basic Policy for Profit Distribution, and Dividends in the Current and Next Fiscal Years

The priorities of the Group are strengthening financial soundness and the foundation for business operations from a long-term perspective and making steady and consistent distributions of earnings to shareholders.

Regarding shareholder returns, we will strive to distribute dividends according to our business performance, while maintaining balance by considering factors such as the enhancement of internal reserves for the Company's business performance and future business plans, with a payout ratio of 40% as a key guideline, and enhance shareholder returns through measures including flexible share buybacks.

For the fiscal year ended November 30, 2024, we paid a dividend of 32 yen per share for the second quarter based on our basic policy. For the year-end dividend, we plan to increase the dividend by 2 yen to 34 yen per share (annual dividend of 66 yen per share), reflecting strong business performance, particularly in the Chemicals Business.

The Company plans to pay a dividend of 68 yen per share for the next fiscal year (for the fiscal year ending November 30, 2025), which is 34 yen for the second quarter and 34 yen for the end of the fiscal year.

2. Basic Approach for the Selection of Accounting Standards

The Group will continue to prepare consolidated financial statements using the generally accepted accounting principles in Japan for the time being to permit comparisons with prior years and with the financial data of other companies.

We will take suitable actions with regard to the application of International Financial Reporting Standards by taking into account associated factors in Japan and other countries.

5

OSAKA ORGANIC CHEMICAL INDUSTRY LTD. (4187) Financial Results for FY11/24

Consolidated Financial Statements and Notes

Consolidated Balance Sheet

(Thousands of yen)

As of November 30, 2023

As of November 30, 2024

Assets

Current assets

Cash and deposits

7,890,809

13,047,614

Notes receivable - trade

25,878

31,414

Electronically recorded monetary claims -

335,183

374,384

operating

Accounts receivable - trade

7,985,781

10,499,381

Contract assets

623,007

721,241

Finished goods

4,558,239

4,799,006

Work in process

1,979,792

2,070,025

Raw materials and supplies

2,175,488

1,989,293

Other

1,540,540

773,069

Allowance for doubtful accounts

(12,736)

(18,415)

Total current assets

27,101,985

34,287,015

Non-current assets

Property, plant and equipment

Buildings and structures

19,448,521

19,683,681

Accumulated depreciation

(10,727,778)

(11,356,487)

Buildings and structures, net

8,720,743

8,327,194

Machinery, equipment and vehicles

34,866,382

36,111,190

Accumulated depreciation

(26,192,631)

(28,580,644)

Machinery, equipment and vehicles, net

8,673,751

7,530,545

Land

2,172,476

2,172,476

Construction in progress

520,490

94,679

Other

3,277,607

3,347,568

Accumulated depreciation

(2,921,604)

(3,057,277)

Other, net

356,003

290,291

Total property, plant and equipment

20,443,464

18,415,187

Intangible assets

Goodwill

43,333

23,333

Other

59,379

50,538

Total intangible assets

102,713

73,871

Investments and other assets

Investment securities

6,500,840

6,197,896

Shares of subsidiaries and associates

-

96,958

Retirement benefit asset

357,945

758,144

Deferred tax assets

209

1,927

Other

129,806

133,712

Total investments and other assets

6,988,802

7,188,638

Total non-current assets

27,534,980

25,677,697

Total assets

54,636,965

59,964,713

6

OSAKA ORGANIC CHEMICAL INDUSTRY LTD. (4187) Financial Results for FY11/24

(Thousands of yen)

As of November 30, 2023

As of November 30, 2024

Liabilities

Current liabilities

Notes and accounts payable - trade

3,802,732

5,924,864

Current portion of bonds payable

25,000

-

Current portion of long-term borrowings

1,728,157

2,188,610

Accounts payable - other

814,077

1,524,265

Income taxes payable

234,679

895,161

Contract liabilities

14,130

45,651

Provision for bonuses for directors (and other

15,590

42,210

officers)

Other

463,683

1,109,114

Total current liabilities

7,098,050

11,729,879

Non-current liabilities

Long-term borrowings

3,169,849

1,337,923

Deferred tax liabilities

628,650

634,911

Provision for share awards for directors (and other

21,107

35,086

officers)

Other

90,085

86,937

Total non-current liabilities

3,909,693

2,094,858

Total liabilities

11,007,743

13,824,737

Net assets

Shareholders' equity

Share capital

3,600,295

3,600,295

Capital surplus

3,511,017

3,513,436

Retained earnings

35,954,913

38,727,951

Treasury shares

(2,709,700)

(3,129,535)

Total shareholders' equity

40,356,525

42,712,148

Accumulated other comprehensive income

Valuation difference on available-for-sale

2,514,638

2,344,090

securities

Foreign currency translation adjustment

125,461

132,235

Remeasurements of defined benefit plans

(12,589)

246,812

Total accumulated other comprehensive income

2,627,510

2,723,138

Non-controlling interests

645,186

704,689

Total net assets

43,629,221

46,139,976

Total liabilities and net assets

54,636,965

59,964,713

7

OSAKA ORGANIC CHEMICAL INDUSTRY LTD. (4187) Financial Results for FY11/24

Consolidated Statements of Income and Comprehensive Income

Consolidated Statement of Income

(Thousands of yen)

For the fiscal year

For the fiscal year

ended November 30, 2023

ended November 30, 2024

Net sales

28,907,186

32,698,809

Cost of sales

20,947,756

23,010,361

Gross profit

7,959,430

9,688,447

Selling, general and administrative expenses

4,382,266

5,079,643

Operating profit

3,577,163

4,608,803

Non-operating income

Interest income

1,693

5,278

Dividend income

165,779

150,135

Foreign exchange gains

34,225

-

Insurance claim income

72,590

-

Other

39,501

50,187

Total non-operating income

313,791

205,602

Non-operating expenses

Interest expenses

7,336

9,326

Foreign exchange losses

-

20,669

Donations

-

27,000

Commission for purchase of treasury shares

3,241

602

Loss on investments in investment partnerships

2,521

2,191

Other

46

640

Total non-operating expenses

13,146

60,431

Ordinary profit

3,877,808

4,753,974

Extraordinary income

Gain on sale of non-current assets

873

-

Gain on sale of investment securities

586,542

815,207

Total extraordinary income

587,415

815,207

Extraordinary losses

Loss on sale of non-current assets

1,889

-

Loss on retirement of non-current assets

7,726

1,608

Total extraordinary losses

9,615

1,608

Profit before income taxes

4,455,607

5,567,573

Income taxes - current

1,146,055

1,486,506

Income taxes - deferred

(51,393)

(36,793)

Total income taxes

1,094,661

1,449,712

Profit

3,360,946

4,117,860

Profit attributable to non-controlling interests

89,959

73,278

Profit attributable to owners of parent

3,270,986

4,044,582

8

Company analysis